The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-amino-6-(4-hydroxy-2-oxo-2H-chromen-3-yl)-4-(3-methoxyphenyl)nicotinonitrile ID: ALA4868909
PubChem CID: 164625158
Max Phase: Preclinical
Molecular Formula: C22H15N3O4
Molecular Weight: 385.38
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: COc1cccc(-c2cc(-c3c(O)c4ccccc4oc3=O)nc(N)c2C#N)c1
Standard InChI: InChI=1S/C22H15N3O4/c1-28-13-6-4-5-12(9-13)15-10-17(25-21(24)16(15)11-23)19-20(26)14-7-2-3-8-18(14)29-22(19)27/h2-10,26H,1H3,(H2,24,25)
Standard InChI Key: ZHSQXZZMKDUQLK-UHFFFAOYSA-N
Molfile:
RDKit 2D
29 32 0 0 0 0 0 0 0 0999 V2000
1.0474 -5.9446 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0462 -6.7720 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7616 -7.1827 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7598 -5.5298 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4757 -5.9410 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4764 -6.7679 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1923 -7.1767 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.9078 -6.7640 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9030 -5.9341 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1867 -5.5248 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6084 -5.5169 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3262 -5.9290 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.0381 -5.5107 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0336 -4.6849 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3111 -4.2791 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6021 -4.6954 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3037 -3.4568 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0163 -3.0360 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0088 -2.2119 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2894 -1.8075 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5761 -2.2291 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5871 -3.0519 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6203 -7.1716 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.1823 -4.6998 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.7452 -4.2702 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.4571 -3.8505 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.7554 -5.9213 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.7154 -1.7941 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.4305 -2.1972 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 1 0
8 9 1 0
9 10 2 0
10 5 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 11 1 0
9 11 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 17 1 0
15 17 1 0
8 23 2 0
10 24 1 0
25 26 3 0
14 25 1 0
13 27 1 0
19 28 1 0
28 29 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 385.38Molecular Weight (Monoisotopic): 385.1063AlogP: 3.69#Rotatable Bonds: 3Polar Surface Area: 122.37Molecular Species: ACIDHBA: 7HBD: 2#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: 5.96CX Basic pKa: 0.84CX LogP: 2.98CX LogD: 1.54Aromatic Rings: 4Heavy Atoms: 29QED Weighted: 0.52Np Likeness Score: -0.49
References 1. Ahmed EY, Elserwy WS, El-Mansy MF, Serry AM, Salem AM, Abdou AM, Abdelrahman BA, Elsayed KH, Abd Elaziz MR.. (2021) Angiokinase inhibition of VEGFR-2, PDGFR and FGFR and cell growth inhibition in lung cancer: Design, synthesis, biological evaluation and molecular docking of novel azaheterocyclic coumarin derivatives., 48 [PMID:34246754 ] [10.1016/j.bmcl.2021.128258 ]